earnings
confidence high
sentiment neutral
materiality 0.65
Owens & Minor Q3 revenue up 5% to $2.7B; GAAP net loss $0.17/shr; adj EPS $0.42; debt cut $198M
ACCENDRA HEALTH INC/VA/
2024-Q3 EPS reported
-$0.87
revenue$8,004,810,000
- Consolidated revenue of $2.7B (+5% YoY); GAAP net loss $(13M) or $(0.17)/share.
- Adjusted EBITDA $142M (+5% YoY); adjusted EPS $0.42 vs $0.44 prior year.
- Total debt reduced by $198M in Q3; management expects sequential growth into Q4.
- Patient Direct and Medical Distribution divisions drove top-line growth.
- Adjusted net income $33.2M vs $34.1M YoY, reflecting higher interest costs.